病态肥胖患者全髋关节置换术前减重手术具成本效益
本研究采用马尔可夫模型,从支付方和社会视角比较病态肥胖合并终末期髋骨关节炎患者直接行全髋关节置换术与术前2年行减重手术两种方案的成本效用。结果显示联合方案在社会视角下更有效且成本更低,为优势策略,超过95%概率具成本效益。
要点
- 病态肥胖合并终末期髋OA患者,THA前2年行减重手术为社会视角下优势策略。
- 联合方案效用13.16高于直接THA的12.26,成本91,717美元低于92,684美元。
- 蒙特卡洛模拟10万样本显示,联合方案在两种视角下均超95%概率具成本效益。
核心结论
- 病态肥胖合并终末期髋OA患者,THA前先行减重手术是改善生活质量并降低社会和支付方成本的具成本效益策略。
研究设计与样本
- 构建状态转移马尔可夫模型,比较直接THA与THA前2年行减重手术两种方案的成本效用。
- 从支付方和社会视角分析,使用直接和间接成本,时间跨度40年。
- 效用、成本和健康状态转移概率来自文献,并进行单因素、双因素和概率敏感性分析。
主要发现
- 社会视角下联合方案效用为13.16,直接THA为12.26。
- 社会视角下联合方案成本为91,717美元,直接THA为92,684美元。
- 联合方案为优势策略,结果在独立模型变量较大范围内稳定。
- 10万样本蒙特卡洛模拟显示,联合方案在支付方和社会视角下均超过95%概率为首选成本效益策略。
关键数值与推荐
- 支付意愿阈值采用标准的100,000美元/质量调整生命年。
- 证据等级为II级。
临床怎么用
- 对病态肥胖合并终末期髋OA患者,可考虑在THA前2年行减重手术以改善成本效益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The cost-effectiveness of bariatric surgery to achieve weight loss prior to total hip arthroplasty (THA), and decrease the complications and costs associated with THA in the morbidly obese, is unknown. This study evaluated the cost-effectiveness of bariatric surgery prior to THA for morbidly obese patients with end-stage hip osteoarthritis (OA). METHODS: A state-transition Markov model was constructed to compare the cost-utility of 2 treatment protocols for patients with morbid obesity and end-stage hip OA: (1) immediate THA and (2) bariatric surgery 2 years prior to THA (combined protocol). The analysis was performed from both a payer and a societal perspective using direct and indirect costs over a 40-year time horizon. Utilities, associated costs, and probabilities for health state transitions were derived from the literature. One-way, 2-way and probabilistic sensitivity analyses were performed to validate the robustness of the base case results, using the standard willingness-to-pay threshold of $100,000/quality-adjusted life years. RESULTS: From the societal perspective, the combined protocol was more effective (13.16 vs 12.26) with less cost ($91,717 vs $92,684) and thus was the dominant strategy over immediate THA. These results were stable across broad ranges for independent model variables. Monte Carlo simulation with 100,000 samples demonstrated that bariatric surgery prior to THA was the preferred cost-effective strategy over 95% of the time from both a societal and payer perspective. CONCLUSION: In the morbidly obese patient with end-stage hip OA, bariatric surgery prior to THA is a cost-effective strategy for improving quality of life and decreasing societal and payer costs. LEVEL OF EVIDENCE: II.
引用
- Premkumar A, Lebrun DG, Sidharthan S, et al. Bariatric Surgery Prior to Total Hip Arthroplasty Is Cost-Effective in Morbidly Obese Patients. J Arthroplasty. 2020. PMID: 32278487. doi:10.1016/j.arth.2020.02.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。